SlideShare a Scribd company logo
1 of 20
Relative measures
• Measures to be
discussed
– Risk/rate ratio
– Prevalence ratio
– Odds ratio
Relative measures
•
• Risk/rate ratio (RR) – aka relative risk
• – “Risk” in relative risk used generically to include risk or rate
• Provides information about relative association between an exposure
and a disease
• The risk/rate of disease in the exposed is compared to the same
measure among the unexposed as a ratio
•RR = Rexposed / Runexposed = Re / Ru
• Where R indicates either risk or rate – (i.e., CI (cumulative
incidence) or ID (incidence density))
Relative measures
• RR can be used to refer generically to these relative
measures
• CIR is the specific term when cumulative incidence is
used
• IDR is the specific term when incidence density is used
• Used to see term RR used generically for any relative
measure (including OR, PR) but current trend is toward
specific terms
Relative measures
• Interpretations of RR:
• Relative difference in the risk/rate of disease between
the exposed and unexposed
• Interpretation of RR=5: Risk/rate of disease in the
exposed is 5 times the risk/rate in the unexposed
• Interpretation of RR=0.5: Risk/rate of disease in the
exposed is 0.5 times the risk/rate in the unexposed
Relative measures
• Example: study of oral contraceptive (OC) use and
bacteriuria among women 16-49 yrs
over 1 year
• RR = ?
• What measures of disease incidence can we estimate
from this data?
• How do we compare them to estimate RR?
Relative measures
• Can estimate CIs
• Take ratio to estimate RR
• RR = CIR = CIe/CIu=
• RR = (27/482)/(77/1908) = 1.39
• Women who use OCs have 1.39 times the risk of
bacteriuria (over 1 year) compared with women who do
not use OCs
• Note that as with CI, CIR is only interpretable with
information on the time period over which it was
calculated
Relative measures
• Prevalence ratio (PR)
• Provides information about relative association between an expo
and a disease, using prevalence as the measure of disease
• – Analogous to RR
• PR = Prevexposed / Prevunexposed = Preve / Prevu
Relative measures
• Interpretations of PR:
• Relative difference in the prevalence of disease
between the exposed and unexposed
• Interpretation of PR=5: Prevalence of disease among
the exposed is 5 times the prevalence in the unexposed
• Interpretation of PR=0.5: Prevalence of disease in the
exposed is 0.5 times the prevalence of disease in the
unexposed
Relative measures
• A brief aside on odds
• Odds – two equivalent definitions
– Odds = number of people with event / number of people without
an event
– Odds = probability of event occurring / probability of event not
occurring = P / (1-P)
• Example:
– 10 people in a classroom of 50 have a cold
– Probability of having a cold = 10/50 = 0.2
– Probability of not having a cold = 40/50 = 0.8
– Odds of having a cold = 10/40 = 0.2/0.8 = 0.25
• Odds range from 0 to positive infinity
Relative measures
• Utility of odds will become apparent when we discuss
study design and analysis of epidemiologic data
– When a disease is rare, odds can be modeled in place of risks
with similar results
– In some study designs (case-control varieties) odds estimate
pseudo-risks/rates (more in study design)
Relative measures
• Odds ratio (OR)
• Provides information about relative association between an expo
and a disease, using odds as the measure of disease
• – Analogous to RR
• •OR = (Pe/(1-Pe))/(Pu/(1-Pu))
• OR = Odds(disease)e / Odds(disease)u
JC: discuss (Disease Odds) vs. (Exposure Odds)
Relative measures
• Interpretations of OR:
• Relative difference in the odds of disease between the
exposed and unexposed
• Interpretation of OR=5: Odds of disease is in the
exposed is 5 times the odds in the unexposed
• Interpretation of OR=0.5: The odds of disease in the
exposed is 0.5 times the odds of disease in the
unexposed
• Note: it is incorrect to interpret the odds ratio as the
risk/rate ratio
– Exception for particular case-control study designs (more in
study design module)
Relative measures
• OR always more extreme than RR (further from null)
– When the disease is rare the values will be close
– Note that this is not relevant for designs in which OR captures a
risk/rate ratio directly (more in study design)
Relative measures
• OR versus RR
• Example:
– Recall the example of students having a cold
• P=0.2
• Odds=0.25
– Say we wanted to compare this classroom to an office
– In the office, 10 out of 100 people have a cold.
• P = 10/100 = 0.1
• Odds = 10/90 = 0.111
– Exposed are students, unexposed are office workers, outcome
is cold
– RR comparing students to workers: RR = 0.2 / 0.1 = 2
– OR comparing students to workers: OR = 0.25 / 0.111 = 2.25
Relative measures
• OR = ?
• OR = Odds(dis)exposed/Odds(dis)unexposed
• OR = (a/b)/(c/d) = ad/bc
• OR = (27x1831)/(77x455) = 1.41
• Women who use OCs have 1.41 times the odds of
bacteriuria compared to women who do not use OCs
JC: mention disease odds vs. exposure odds
Relative measures
• Formula review
– RR = Re / Ru
– PR = Preve / Prevu
– OR = (Pe/(1-Pe))/(Pu/(1-Pu))
– OR = Odds(dis)e/Odds(dis)u
Relative measures
• Exercise for home (discuss in lab)
• Hypothetical RCT for injection drug users
– Primary outcomes are cessation of drug use
– HIV as a secondary outcome of interest
Relative measures
• Exercise at home / in lab
• 60 people randomized to a 12-month residential
detoxification program
– 49 tested HIV negative at the start of the trial
– At the end of the trial, 5 participants tested positive
for HIV who had been negative at the start of the trial
• 60 people randomized to 12-months of
outpatient treatment
– 50 tested HIV negative at the start of the trial
– At the end of the trial, 3 participants tested positive
for HIV who had been negative at the start of the trial
Relative measures
• Exercise at home / in lab
• Calculate and interpret relative measures of
association of potential interest from these trial
results

More Related Content

What's hot

2. ph250b.14 measures of association 1
2.  ph250b.14  measures of association 12.  ph250b.14  measures of association 1
2. ph250b.14 measures of association 1A M
 
Introduction to biostatistics
Introduction to biostatisticsIntroduction to biostatistics
Introduction to biostatisticsINAAMUL HAQ
 
Measures of association 2013
Measures of association 2013Measures of association 2013
Measures of association 2013dinahoefer11
 
6.4.3 designs cumulative
6.4.3 designs cumulative6.4.3 designs cumulative
6.4.3 designs cumulativeA M
 
1.1 big picture
1.1 big picture1.1 big picture
1.1 big pictureA M
 
0. introduction to epidemiology
0.  introduction to epidemiology0.  introduction to epidemiology
0. introduction to epidemiologyA M
 
Basics in Epidemiology & Biostatistics 1 RSS6 2014
Basics in Epidemiology & Biostatistics 1 RSS6 2014Basics in Epidemiology & Biostatistics 1 RSS6 2014
Basics in Epidemiology & Biostatistics 1 RSS6 2014RSS6
 
3.5.1 information bias
3.5.1 information bias3.5.1 information bias
3.5.1 information biasA M
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute RiskTauseef Jawaid
 
MD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsMD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsBernard Deepal W. Jayamanne
 
Measuring Association
Measuring AssociationMeasuring Association
Measuring AssociationPerez Eric
 
1.5.5 measures – cumulative incidence
1.5.5 measures – cumulative incidence1.5.5 measures – cumulative incidence
1.5.5 measures – cumulative incidenceA M
 
4. case control studies
4. case control studies4. case control studies
4. case control studiesNaveen Phuyal
 
Case control study - Part 2
Case control study - Part 2Case control study - Part 2
Case control study - Part 2Rizwan S A
 
Introduction to biostatistics
Introduction to biostatisticsIntroduction to biostatistics
Introduction to biostatisticsshivamdixit57
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological StudiesPerez Eric
 
5.3.1 causal em
5.3.1 causal em5.3.1 causal em
5.3.1 causal emA M
 
Lecture 5 case control & cross-sectional spring 2013
Lecture 5  case control & cross-sectional spring 2013Lecture 5  case control & cross-sectional spring 2013
Lecture 5 case control & cross-sectional spring 2013maythayel
 

What's hot (20)

2. ph250b.14 measures of association 1
2.  ph250b.14  measures of association 12.  ph250b.14  measures of association 1
2. ph250b.14 measures of association 1
 
Introduction to biostatistics
Introduction to biostatisticsIntroduction to biostatistics
Introduction to biostatistics
 
Measures of association 2013
Measures of association 2013Measures of association 2013
Measures of association 2013
 
6.4.3 designs cumulative
6.4.3 designs cumulative6.4.3 designs cumulative
6.4.3 designs cumulative
 
1.1 big picture
1.1 big picture1.1 big picture
1.1 big picture
 
0. introduction to epidemiology
0.  introduction to epidemiology0.  introduction to epidemiology
0. introduction to epidemiology
 
Basics in Epidemiology & Biostatistics 1 RSS6 2014
Basics in Epidemiology & Biostatistics 1 RSS6 2014Basics in Epidemiology & Biostatistics 1 RSS6 2014
Basics in Epidemiology & Biostatistics 1 RSS6 2014
 
3.5.1 information bias
3.5.1 information bias3.5.1 information bias
3.5.1 information bias
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute Risk
 
MD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsMD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and Statistics
 
Measuring Association
Measuring AssociationMeasuring Association
Measuring Association
 
Measuring of risk
Measuring of riskMeasuring of risk
Measuring of risk
 
1.5.5 measures – cumulative incidence
1.5.5 measures – cumulative incidence1.5.5 measures – cumulative incidence
1.5.5 measures – cumulative incidence
 
4. case control studies
4. case control studies4. case control studies
4. case control studies
 
Case control study - Part 2
Case control study - Part 2Case control study - Part 2
Case control study - Part 2
 
Introduction to biostatistics
Introduction to biostatisticsIntroduction to biostatistics
Introduction to biostatistics
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological Studies
 
5.3.1 causal em
5.3.1 causal em5.3.1 causal em
5.3.1 causal em
 
Biostatistics
BiostatisticsBiostatistics
Biostatistics
 
Lecture 5 case control & cross-sectional spring 2013
Lecture 5  case control & cross-sectional spring 2013Lecture 5  case control & cross-sectional spring 2013
Lecture 5 case control & cross-sectional spring 2013
 

Viewers also liked

2.2 scales of measures
2.2 scales of measures2.2 scales of measures
2.2 scales of measuresA M
 
AHS13 Anastasia Boulais — Is Sun Worshipping Increasing Your Risk of Melanoma?
AHS13 Anastasia Boulais — Is Sun Worshipping Increasing Your Risk of Melanoma? AHS13 Anastasia Boulais — Is Sun Worshipping Increasing Your Risk of Melanoma?
AHS13 Anastasia Boulais — Is Sun Worshipping Increasing Your Risk of Melanoma? Ancestral Health Society
 
Malimu measures of disease frequency
Malimu measures of disease frequencyMalimu measures of disease frequency
Malimu measures of disease frequencyMiharbi Ignasm
 
unmatched case control studies
unmatched case control studiesunmatched case control studies
unmatched case control studiesMrinmoy Bharadwaz
 
nutrition & infection
 nutrition & infection nutrition & infection
nutrition & infectionMiharbi Ignasm
 
Melanoma – Prevention, Detection and Treatment
Melanoma – Prevention, Detection and TreatmentMelanoma – Prevention, Detection and Treatment
Melanoma – Prevention, Detection and TreatmentSummit Health
 
Logistic Regression in Case-Control Study
Logistic Regression in Case-Control StudyLogistic Regression in Case-Control Study
Logistic Regression in Case-Control StudySatish Gupta
 
NTI2010 Policy Politics And You Act With Intention
NTI2010 Policy Politics And You Act With IntentionNTI2010 Policy Politics And You Act With Intention
NTI2010 Policy Politics And You Act With IntentionTodd_Grivetti
 
4. Calculate samplesize for cross-sectional studies
4. Calculate samplesize for cross-sectional studies4. Calculate samplesize for cross-sectional studies
4. Calculate samplesize for cross-sectional studiesAzmi Mohd Tamil
 
3. Calculate samplesize for prevalence studies
3. Calculate samplesize for prevalence studies3. Calculate samplesize for prevalence studies
3. Calculate samplesize for prevalence studiesAzmi Mohd Tamil
 
Cross sectional study overview
Cross sectional study overviewCross sectional study overview
Cross sectional study overviewherunyu
 
Logistic regression
Logistic regressionLogistic regression
Logistic regressionsaba khan
 
Public Health Questions and Answers for Students
Public Health Questions and Answers for StudentsPublic Health Questions and Answers for Students
Public Health Questions and Answers for StudentsNayyar Kazmi
 
Multiple choice questions with answers
Multiple choice questions with answersMultiple choice questions with answers
Multiple choice questions with answersClassic Tech
 

Viewers also liked (18)

2.2 scales of measures
2.2 scales of measures2.2 scales of measures
2.2 scales of measures
 
AHS13 Anastasia Boulais — Is Sun Worshipping Increasing Your Risk of Melanoma?
AHS13 Anastasia Boulais — Is Sun Worshipping Increasing Your Risk of Melanoma? AHS13 Anastasia Boulais — Is Sun Worshipping Increasing Your Risk of Melanoma?
AHS13 Anastasia Boulais — Is Sun Worshipping Increasing Your Risk of Melanoma?
 
Malimu measures of disease frequency
Malimu measures of disease frequencyMalimu measures of disease frequency
Malimu measures of disease frequency
 
unmatched case control studies
unmatched case control studiesunmatched case control studies
unmatched case control studies
 
nutrition & infection
 nutrition & infection nutrition & infection
nutrition & infection
 
Melanoma – Prevention, Detection and Treatment
Melanoma – Prevention, Detection and TreatmentMelanoma – Prevention, Detection and Treatment
Melanoma – Prevention, Detection and Treatment
 
Logistic Regression in Case-Control Study
Logistic Regression in Case-Control StudyLogistic Regression in Case-Control Study
Logistic Regression in Case-Control Study
 
NTI2010 Policy Politics And You Act With Intention
NTI2010 Policy Politics And You Act With IntentionNTI2010 Policy Politics And You Act With Intention
NTI2010 Policy Politics And You Act With Intention
 
4. Calculate samplesize for cross-sectional studies
4. Calculate samplesize for cross-sectional studies4. Calculate samplesize for cross-sectional studies
4. Calculate samplesize for cross-sectional studies
 
Cross sectional study
Cross sectional studyCross sectional study
Cross sectional study
 
3. Calculate samplesize for prevalence studies
3. Calculate samplesize for prevalence studies3. Calculate samplesize for prevalence studies
3. Calculate samplesize for prevalence studies
 
3 cross sectional study
3 cross sectional study3 cross sectional study
3 cross sectional study
 
Cross sectional study overview
Cross sectional study overviewCross sectional study overview
Cross sectional study overview
 
Epidemiology ppt
Epidemiology pptEpidemiology ppt
Epidemiology ppt
 
Logistic regression
Logistic regressionLogistic regression
Logistic regression
 
Public Health Questions and Answers for Students
Public Health Questions and Answers for StudentsPublic Health Questions and Answers for Students
Public Health Questions and Answers for Students
 
Epidemiology notes
Epidemiology notesEpidemiology notes
Epidemiology notes
 
Multiple choice questions with answers
Multiple choice questions with answersMultiple choice questions with answers
Multiple choice questions with answers
 

Similar to 2.4.1 relative measures

measures of association.pptx
measures of association.pptxmeasures of association.pptx
measures of association.pptxAyon Gupta
 
Research Designs
Research DesignsResearch Designs
Research DesignsAravind L R
 
Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...
Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...
Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...Dr. Aryan (Anish Dhakal)
 
Mesures of Disease Association (1).ppt
Mesures of Disease Association (1).pptMesures of Disease Association (1).ppt
Mesures of Disease Association (1).pptchcjayanagara
 
Cohort study design.ppt Epidemiology medical
Cohort study design.ppt Epidemiology medicalCohort study design.ppt Epidemiology medical
Cohort study design.ppt Epidemiology medicalSoravSorout
 
Choosing appropriate statistical test RSS6 2104
Choosing appropriate statistical test RSS6 2104Choosing appropriate statistical test RSS6 2104
Choosing appropriate statistical test RSS6 2104RSS6
 
Relative and Attributable Risk For Graduate and Postgraduate Students
Relative and Attributable Risk For Graduate and Postgraduate StudentsRelative and Attributable Risk For Graduate and Postgraduate Students
Relative and Attributable Risk For Graduate and Postgraduate StudentsTauseef Jawaid
 
Lecture measure of effect and disase causation
Lecture measure of effect and disase causationLecture measure of effect and disase causation
Lecture measure of effect and disase causationmohamed abdisalam dahir
 
Peds journal club 2 -diagnostic test
Peds journal club 2 -diagnostic testPeds journal club 2 -diagnostic test
Peds journal club 2 -diagnostic testcoolboy101pk
 
Epidemological methods
Epidemological methodsEpidemological methods
Epidemological methodsKundan Singh
 
Measures of association
Measures of associationMeasures of association
Measures of associationIAU Dent
 
Techniques in clinical epidemiology
Techniques in clinical epidemiologyTechniques in clinical epidemiology
Techniques in clinical epidemiologyBhoj Raj Singh
 
ODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONKanhu Charan
 
Imran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysisImran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysisImran Rizvi
 
3.5.2 selection bias
3.5.2 selection bias3.5.2 selection bias
3.5.2 selection biasA M
 
Oral Epidemiology I
Oral Epidemiology IOral Epidemiology I
Oral Epidemiology IIAU Dent
 
Ct lecture 5. descriptive analysis of categorical variables
Ct lecture 5. descriptive analysis of categorical variablesCt lecture 5. descriptive analysis of categorical variables
Ct lecture 5. descriptive analysis of categorical variablesHau Pham
 

Similar to 2.4.1 relative measures (20)

measures of association.pptx
measures of association.pptxmeasures of association.pptx
measures of association.pptx
 
Research Designs
Research DesignsResearch Designs
Research Designs
 
Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...
Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...
Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...
 
Risk Comparison
Risk ComparisonRisk Comparison
Risk Comparison
 
Mesures of Disease Association (1).ppt
Mesures of Disease Association (1).pptMesures of Disease Association (1).ppt
Mesures of Disease Association (1).ppt
 
Cohort study design.ppt Epidemiology medical
Cohort study design.ppt Epidemiology medicalCohort study design.ppt Epidemiology medical
Cohort study design.ppt Epidemiology medical
 
Choosing appropriate statistical test RSS6 2104
Choosing appropriate statistical test RSS6 2104Choosing appropriate statistical test RSS6 2104
Choosing appropriate statistical test RSS6 2104
 
Relative and Attributable Risk For Graduate and Postgraduate Students
Relative and Attributable Risk For Graduate and Postgraduate StudentsRelative and Attributable Risk For Graduate and Postgraduate Students
Relative and Attributable Risk For Graduate and Postgraduate Students
 
Lecture measure of effect and disase causation
Lecture measure of effect and disase causationLecture measure of effect and disase causation
Lecture measure of effect and disase causation
 
Peds journal club 2 -diagnostic test
Peds journal club 2 -diagnostic testPeds journal club 2 -diagnostic test
Peds journal club 2 -diagnostic test
 
Epidemological methods
Epidemological methodsEpidemological methods
Epidemological methods
 
Measures of association
Measures of associationMeasures of association
Measures of association
 
Techniques in clinical epidemiology
Techniques in clinical epidemiologyTechniques in clinical epidemiology
Techniques in clinical epidemiology
 
ODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATION
 
Imran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysisImran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysis
 
3.5.2 selection bias
3.5.2 selection bias3.5.2 selection bias
3.5.2 selection bias
 
Types of study design
Types of study designTypes of study design
Types of study design
 
Oral Epidemiology I
Oral Epidemiology IOral Epidemiology I
Oral Epidemiology I
 
Cross sec study dr rahul
Cross sec study dr rahulCross sec study dr rahul
Cross sec study dr rahul
 
Ct lecture 5. descriptive analysis of categorical variables
Ct lecture 5. descriptive analysis of categorical variablesCt lecture 5. descriptive analysis of categorical variables
Ct lecture 5. descriptive analysis of categorical variables
 

More from A M

Transparency7
Transparency7Transparency7
Transparency7A M
 
Transparency6
Transparency6Transparency6
Transparency6A M
 
Transparency5
Transparency5Transparency5
Transparency5A M
 
Transparency4
Transparency4Transparency4
Transparency4A M
 
Transparency3
Transparency3Transparency3
Transparency3A M
 
Transparency2
Transparency2Transparency2
Transparency2A M
 
Transparency1
Transparency1Transparency1
Transparency1A M
 
5.3.5 causal inference in research
5.3.5 causal inference in research5.3.5 causal inference in research
5.3.5 causal inference in researchA M
 
5.3.4 reporting em
5.3.4 reporting em5.3.4 reporting em
5.3.4 reporting emA M
 
5.3.3 potential outcomes em
5.3.3 potential outcomes em5.3.3 potential outcomes em
5.3.3 potential outcomes emA M
 
5.3.2 sufficient cause em
5.3.2 sufficient cause em5.3.2 sufficient cause em
5.3.2 sufficient cause emA M
 
5.2.3 dags for selection bias
5.2.3 dags for selection bias5.2.3 dags for selection bias
5.2.3 dags for selection biasA M
 
5.2.2 dags for confounding
5.2.2 dags for confounding5.2.2 dags for confounding
5.2.2 dags for confoundingA M
 
5.1.3 hills criteria
5.1.3 hills criteria5.1.3 hills criteria
5.1.3 hills criteriaA M
 
5.1.2 counterfactual framework
5.1.2 counterfactual framework5.1.2 counterfactual framework
5.1.2 counterfactual frameworkA M
 
5.1.1 sufficient component cause model
5.1.1 sufficient component cause model5.1.1 sufficient component cause model
5.1.1 sufficient component cause modelA M
 
5.2.1 dags
5.2.1 dags5.2.1 dags
5.2.1 dagsA M
 
4.4. effect modification
4.4. effect modification4.4. effect modification
4.4. effect modificationA M
 
4.5. logistic regression
4.5. logistic regression4.5. logistic regression
4.5. logistic regressionA M
 
4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratificationA M
 

More from A M (20)

Transparency7
Transparency7Transparency7
Transparency7
 
Transparency6
Transparency6Transparency6
Transparency6
 
Transparency5
Transparency5Transparency5
Transparency5
 
Transparency4
Transparency4Transparency4
Transparency4
 
Transparency3
Transparency3Transparency3
Transparency3
 
Transparency2
Transparency2Transparency2
Transparency2
 
Transparency1
Transparency1Transparency1
Transparency1
 
5.3.5 causal inference in research
5.3.5 causal inference in research5.3.5 causal inference in research
5.3.5 causal inference in research
 
5.3.4 reporting em
5.3.4 reporting em5.3.4 reporting em
5.3.4 reporting em
 
5.3.3 potential outcomes em
5.3.3 potential outcomes em5.3.3 potential outcomes em
5.3.3 potential outcomes em
 
5.3.2 sufficient cause em
5.3.2 sufficient cause em5.3.2 sufficient cause em
5.3.2 sufficient cause em
 
5.2.3 dags for selection bias
5.2.3 dags for selection bias5.2.3 dags for selection bias
5.2.3 dags for selection bias
 
5.2.2 dags for confounding
5.2.2 dags for confounding5.2.2 dags for confounding
5.2.2 dags for confounding
 
5.1.3 hills criteria
5.1.3 hills criteria5.1.3 hills criteria
5.1.3 hills criteria
 
5.1.2 counterfactual framework
5.1.2 counterfactual framework5.1.2 counterfactual framework
5.1.2 counterfactual framework
 
5.1.1 sufficient component cause model
5.1.1 sufficient component cause model5.1.1 sufficient component cause model
5.1.1 sufficient component cause model
 
5.2.1 dags
5.2.1 dags5.2.1 dags
5.2.1 dags
 
4.4. effect modification
4.4. effect modification4.4. effect modification
4.4. effect modification
 
4.5. logistic regression
4.5. logistic regression4.5. logistic regression
4.5. logistic regression
 
4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxEsquimalt MFRC
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSCeline George
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdfssuserdda66b
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxDr. Sarita Anand
 

Recently uploaded (20)

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 

2.4.1 relative measures

  • 1. Relative measures • Measures to be discussed – Risk/rate ratio – Prevalence ratio – Odds ratio
  • 2. Relative measures • • Risk/rate ratio (RR) – aka relative risk • – “Risk” in relative risk used generically to include risk or rate • Provides information about relative association between an exposure and a disease • The risk/rate of disease in the exposed is compared to the same measure among the unexposed as a ratio •RR = Rexposed / Runexposed = Re / Ru • Where R indicates either risk or rate – (i.e., CI (cumulative incidence) or ID (incidence density))
  • 3. Relative measures • RR can be used to refer generically to these relative measures • CIR is the specific term when cumulative incidence is used • IDR is the specific term when incidence density is used • Used to see term RR used generically for any relative measure (including OR, PR) but current trend is toward specific terms
  • 4. Relative measures • Interpretations of RR: • Relative difference in the risk/rate of disease between the exposed and unexposed • Interpretation of RR=5: Risk/rate of disease in the exposed is 5 times the risk/rate in the unexposed • Interpretation of RR=0.5: Risk/rate of disease in the exposed is 0.5 times the risk/rate in the unexposed
  • 5. Relative measures • Example: study of oral contraceptive (OC) use and bacteriuria among women 16-49 yrs over 1 year • RR = ? • What measures of disease incidence can we estimate from this data? • How do we compare them to estimate RR?
  • 6. Relative measures • Can estimate CIs • Take ratio to estimate RR • RR = CIR = CIe/CIu= • RR = (27/482)/(77/1908) = 1.39 • Women who use OCs have 1.39 times the risk of bacteriuria (over 1 year) compared with women who do not use OCs • Note that as with CI, CIR is only interpretable with information on the time period over which it was calculated
  • 7. Relative measures • Prevalence ratio (PR) • Provides information about relative association between an expo and a disease, using prevalence as the measure of disease • – Analogous to RR • PR = Prevexposed / Prevunexposed = Preve / Prevu
  • 8. Relative measures • Interpretations of PR: • Relative difference in the prevalence of disease between the exposed and unexposed • Interpretation of PR=5: Prevalence of disease among the exposed is 5 times the prevalence in the unexposed • Interpretation of PR=0.5: Prevalence of disease in the exposed is 0.5 times the prevalence of disease in the unexposed
  • 9. Relative measures • A brief aside on odds • Odds – two equivalent definitions – Odds = number of people with event / number of people without an event – Odds = probability of event occurring / probability of event not occurring = P / (1-P) • Example: – 10 people in a classroom of 50 have a cold – Probability of having a cold = 10/50 = 0.2 – Probability of not having a cold = 40/50 = 0.8 – Odds of having a cold = 10/40 = 0.2/0.8 = 0.25 • Odds range from 0 to positive infinity
  • 10. Relative measures • Utility of odds will become apparent when we discuss study design and analysis of epidemiologic data – When a disease is rare, odds can be modeled in place of risks with similar results – In some study designs (case-control varieties) odds estimate pseudo-risks/rates (more in study design)
  • 11.
  • 12. Relative measures • Odds ratio (OR) • Provides information about relative association between an expo and a disease, using odds as the measure of disease • – Analogous to RR • •OR = (Pe/(1-Pe))/(Pu/(1-Pu)) • OR = Odds(disease)e / Odds(disease)u JC: discuss (Disease Odds) vs. (Exposure Odds)
  • 13. Relative measures • Interpretations of OR: • Relative difference in the odds of disease between the exposed and unexposed • Interpretation of OR=5: Odds of disease is in the exposed is 5 times the odds in the unexposed • Interpretation of OR=0.5: The odds of disease in the exposed is 0.5 times the odds of disease in the unexposed • Note: it is incorrect to interpret the odds ratio as the risk/rate ratio – Exception for particular case-control study designs (more in study design module)
  • 14. Relative measures • OR always more extreme than RR (further from null) – When the disease is rare the values will be close – Note that this is not relevant for designs in which OR captures a risk/rate ratio directly (more in study design)
  • 15. Relative measures • OR versus RR • Example: – Recall the example of students having a cold • P=0.2 • Odds=0.25 – Say we wanted to compare this classroom to an office – In the office, 10 out of 100 people have a cold. • P = 10/100 = 0.1 • Odds = 10/90 = 0.111 – Exposed are students, unexposed are office workers, outcome is cold – RR comparing students to workers: RR = 0.2 / 0.1 = 2 – OR comparing students to workers: OR = 0.25 / 0.111 = 2.25
  • 16. Relative measures • OR = ? • OR = Odds(dis)exposed/Odds(dis)unexposed • OR = (a/b)/(c/d) = ad/bc • OR = (27x1831)/(77x455) = 1.41 • Women who use OCs have 1.41 times the odds of bacteriuria compared to women who do not use OCs JC: mention disease odds vs. exposure odds
  • 17. Relative measures • Formula review – RR = Re / Ru – PR = Preve / Prevu – OR = (Pe/(1-Pe))/(Pu/(1-Pu)) – OR = Odds(dis)e/Odds(dis)u
  • 18. Relative measures • Exercise for home (discuss in lab) • Hypothetical RCT for injection drug users – Primary outcomes are cessation of drug use – HIV as a secondary outcome of interest
  • 19. Relative measures • Exercise at home / in lab • 60 people randomized to a 12-month residential detoxification program – 49 tested HIV negative at the start of the trial – At the end of the trial, 5 participants tested positive for HIV who had been negative at the start of the trial • 60 people randomized to 12-months of outpatient treatment – 50 tested HIV negative at the start of the trial – At the end of the trial, 3 participants tested positive for HIV who had been negative at the start of the trial
  • 20. Relative measures • Exercise at home / in lab • Calculate and interpret relative measures of association of potential interest from these trial results